A COVID-19 vaccine made in Taiwan by Medigen Vaccine Biologics Corp. has received emergency use authorization (EUA) in Paraguay after the unblinding of a Phase 3 clinical trial conducted in the South American country, the company said in a statement Monday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Politics
Presidential Office to hold forum on Taiwan's whole-of-society resilience
09/16/2026 02:32 PM - Society
Chiayi tries to sell public on new Mid-Autumn delicacy: Crocodile leg
09/16/2026 02:16 PM - Culture
Taiwan work makes National Book Award for Translated Literature longlist
09/16/2026 02:11 PM - Business
Taiwan shares close up 0.74%
09/16/2026 01:51 PM - Politics
Ukraine urged to stand by, help strengthen Taiwan: NGO
09/16/2026 01:41 PM